Chinese University of Hong Kong: Crohn Disease trials

The registry lists 14 Crohn Disease studies with Chinese University of Hong Kong as lead sponsor. 4 are open to participants now and 0 have results posted.

No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel DiseaseRecruitingNCT05598489
• Global IBD Visualization of Epidemiology Studies (GIVES) in the 21st CenturyRecruitingNCT04748627
• Safety and Efficacy of Fecal Microbiota TransplantationRecruitingNCT04014413Not applicable
• GWA Study in Patients With Inflammatory Bowel DiseaseRecruitingNCT01140789
• A Pilot Study of FMT on CD Patients With AIECActive, not recruitingNCT05611866Not applicable
• Mother-to-Infant Transfer of Bacteriome, Fungome, Virome, and Metabolome in Health and Crohn's DiseaseActive, not recruitingNCT05112497
• Stopping Biological Therapy in PCD StudyWithdrawnNCT04129723Not applicable
• A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBDStatus unknownNCT04079335
• A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Response to Biological Therapy in Patients With CDTerminatedNCT03994224
• Tight Control Management in Perianal Crohn's DiseaseStatus unknownNCT03861689Not applicable
• The ENIGMA Study: Eastern Inflammatory Bowel Disease Gut MicrobiotaStatus unknownNCT03462875
• The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMIDCompletedNCT02135289
• Epidemiology of IBD in Hong Kong: An Inception Cohort and Follow up StudyCompletedNCT02131168
• Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic DiseaseTerminatedNCT02128503Not applicable